Ignite Creation Date:
2025-12-24 @ 4:40 PM
Ignite Modification Date:
2025-12-29 @ 4:33 AM
Study NCT ID:
NCT03430466
Status:
TERMINATED
Last Update Posted:
2020-08-12
First Post:
2018-02-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Anti PD-L1 Antibody + Anti CTLA-4 Antibody in Combination With Hormone Therapy in Patients With Hormone Receptor Positive HER2-negative Recurrent or Metastatic Breast Cancer
Sponsor:
Kyoto Breast Cancer Research Network
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
kbcrnb001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None